Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemafibrate in severe hypertriglyceridemia with mild or moderate renal impairment
2016-001518-39Phase 3Completed
- Sponsor
- Kowa Research Institute, Inc.
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pemafibrate in hypertriglyceridemia and hyperlipidemia (3 arms), sponsored by Kowa Research Institute, Inc. Primary endpoint: Primary efficacy endpoint. Started Nov 2016; status: completed.
02
Drugs
pemafibrate
03
Conditions
hypertriglyceridemiahyperlipidemia
Beyond the preview
Go deeper on 2016-001518-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001518-39.